Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Castell

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Discovery|July 9, 2015
Targeting MYC Translation in Colorectal CancerAlina Castell, Lars-Gunnar Larsson
Acta Crystallographica. Section D, Biological Crystallography|May 7, 2010
Structural analysis of mycobacterial branched-chain aminotransferase: implications for inhibitor designAlina Castell, Christian Mille, Torsten Unge
Genes|July 1, 2017
MYC Modulation around the CDK2/p27/SKP2 AxisPer Hydbring, Alina Castell, Lars-Gunnar Larsson
Protein Science : a Publication of the Protein Society|September 12, 2006
Structure and function of Rv0130, a conserved hypothetical protein from Mycobacterium tuberculosisPatrik Johansson, Alina Castell, T Alwyn Jones, et al.
Protein Science : a Publication of the Protein Society|July 1, 2005
Rv0216, a conserved hypothetical protein from Mycobacterium tuberculosis that is essential for bacterial survival during infection, has a double hotdog foldAlina Castell, Patrik Johansson, Torsten Unge, et al.
Molecular Cancer Research : MCR|August 26, 2004
Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblastsAnne Hultquist, Cihan Cetinkaya, Siqin Wu, et al.
Biochemistry|September 11, 2015
Structures of Mycobacterium tuberculosis Anthranilate Phosphoribosyltransferase Variants Reveal the Conformational Changes That Facilitate Delivery of the Substrate to the Active SiteTammie V M Cookson, Genevieve L Evans, Alina Castell, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Cell Cycle (Georgetown, Tex.)|December 12, 2018
MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblastsFan Zhang, Siti Mariam Zakaria, Vedrana Högqvist Tabor, et al.
The Biochemical Journal|April 10, 2014
Alternative substrates reveal catalytic cycle and key binding events in the reaction catalysed by anthranilate phosphoribosyltransferase from Mycobacterium tuberculosisTammie V M Cookson, Alina Castell, Esther M M Bulloch, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Discovery|July 9, 2015
Targeting MYC Translation in Colorectal CancerAlina Castell, Lars-Gunnar Larsson
Acta Crystallographica. Section D, Biological Crystallography|May 7, 2010
Structural analysis of mycobacterial branched-chain aminotransferase: implications for inhibitor designAlina Castell, Christian Mille, Torsten Unge
Genes|July 1, 2017
MYC Modulation around the CDK2/p27/SKP2 AxisPer Hydbring, Alina Castell, Lars-Gunnar Larsson
Protein Science : a Publication of the Protein Society|September 12, 2006
Structure and function of Rv0130, a conserved hypothetical protein from Mycobacterium tuberculosisPatrik Johansson, Alina Castell, T Alwyn Jones, et al.
Protein Science : a Publication of the Protein Society|July 1, 2005
Rv0216, a conserved hypothetical protein from Mycobacterium tuberculosis that is essential for bacterial survival during infection, has a double hotdog foldAlina Castell, Patrik Johansson, Torsten Unge, et al.
Molecular Cancer Research : MCR|August 26, 2004
Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblastsAnne Hultquist, Cihan Cetinkaya, Siqin Wu, et al.
Biochemistry|September 11, 2015
Structures of Mycobacterium tuberculosis Anthranilate Phosphoribosyltransferase Variants Reveal the Conformational Changes That Facilitate Delivery of the Substrate to the Active SiteTammie V M Cookson, Genevieve L Evans, Alina Castell, et al.
Investigational New Drugs|October 14, 2020
The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cellsDalal AlSultan, Emma Kavanagh, Shane O'Grady, et al.
Cell Cycle (Georgetown, Tex.)|December 12, 2018
MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblastsFan Zhang, Siti Mariam Zakaria, Vedrana Högqvist Tabor, et al.
The Biochemical Journal|April 10, 2014
Alternative substrates reveal catalytic cycle and key binding events in the reaction catalysed by anthranilate phosphoribosyltransferase from Mycobacterium tuberculosisTammie V M Cookson, Alina Castell, Esther M M Bulloch, et al.
Pageof 2